Marwan Sabbagh, MD: How Aducanumab Impacts Future Studies
The director of the Lou Ruvo Center for Brain Health and neurologist at Cleveland Clinic discussed how Alzheimer disease research may change if aducanumab becomes approved.
Marwan Sabbagh, MD: Outlook of Aducanumab in Alzheimer Disease
The director of the Lou Ruvo Center for Brain Health and neurologist at Cleveland Clinic discussed the potential of aducanumab and the amyloid theory in patients with Alzheimer disease.